 Connection
Larry Dumont to United States
This is a "connection" page, showing publications Larry Dumont has written about United States.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.118 |
|
|
|
-
Dumont LJ, Kleinman S, Murphy JR, Lippincott R, Schuyler R, Houghton J, Metzel P. Screening of single-donor apheresis platelets for bacterial contamination: the PASSPORT study results. Transfusion. 2010 Mar; 50(3):589-99.
Score: 0.025
-
Dumont LJ, AuBuchon JP. Evaluation of proposed FDA criteria for the evaluation of radiolabeled red cell recovery trials. Transfusion. 2008 Jun; 48(6):1053-60.
Score: 0.022
-
Senefeld JW, Johnson PW, Kunze KL, Bloch EM, van Helmond N, Golafshar MA, Klassen SA, Klompas AM, Sexton MA, Diaz Soto JC, Grossman BJ, Tobian AAR, Goel R, Wiggins CC, Bruno KA, van Buskirk CM, Stubbs JR, Winters JL, Casadevall A, Paneth NS, Shaz BH, Petersen MM, Sachais BS, Buras MR, Wieczorek MA, Russoniello B, Dumont LJ, Baker SE, Vassallo RR, Shepherd JRA, Young PP, Verdun NC, Marks P, Haley NR, Rea RF, Katz L, Herasevich V, Waxman DA, Whelan ER, Bergman A, Clayburn AJ, Grabowski MK, Larson KF, Ripoll JG, Andersen KJ, Vogt MNP, Dennis JJ, Regimbal RJ, Bauer PR, Blair JE, Buchholtz ZA, Pletsch MC, Wright K, Greenshields JT, Joyner MJ, Wright RS, Carter RE, Fairweather D. Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: A national registry study. PLoS Med. 2021 12; 18(12):e1003872.
Score: 0.014
-
Vassallo RR, Dumont LJ, Bravo MD, Hazegh K, Kamel H. Progression and Predictors of SARS-CoV-2 Antibody Seroreactivity In US Blood Donors. Transfus Med Rev. 2021 07; 35(3):8-15.
Score: 0.014
-
Vassallo RR, Kamel H, Dumont LJ, Bravo MD. The evolution of COVID-19 vaccination within a US blood center. Transfusion. 2021 09; 61(9):2528-2529.
Score: 0.014
-
Hazegh K, Bravo MD, Kamel H, Dumont L, Kanias T. The prevalence and demographic determinants of blood donors receiving testosterone replacement therapy at a large USA blood service organization. Transfusion. 2020 05; 60(5):947-954.
Score: 0.013
-
Dunbar NM, Dumont LJ, Szczepiorkowski ZM. How do we implement Day 6 and Day 7 platelets at a hospital-based transfusion service? Transfusion. 2016 06; 56(6):1262-6.
Score: 0.010
-
Kleinman S, Dumont LJ, Tomasulo P, Bianco C, Katz L, Benjamin RJ, Gajic O, Brecher ME. The impact of discontinuation of 7-day storage of apheresis platelets (PASSPORT) on recipient safety: an illustration of the need for proper risk assessments. Transfusion. 2009 May; 49(5):903-12.
Score: 0.006
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|